Is BRIGHT MINDS BIOSCIENCES INC. (DRUG) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.0% / 30% | 11.0% / 30% | 0.1% / 30% | N/A | ✓ HALAL |
| DJIM | 0.0% / 33% | 11.0% / 33% | 0.1% / 33% | N/A | ✓ HALAL |
| MSCI | 0.1% / 33% | 98.2% / 33% | 0.5% / 33% | N/A | ✗ NOT HALAL |
| S&P | 0.0% / 33% | 11.0% / 33% | 0.1% / 33% | N/A | ✓ HALAL |
| FTSE | 0.1% / 33% | 98.2% / 33% | 0.5% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -27.0% | |
| Return on Assets (ROA) | -15.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$9M |
| Free Cash Flow | -$9M |
| Total Debt | $125,777 |
| Debt-to-Equity | 0.1 |
| Current Ratio | 57.4 |
| Total Assets | $84M |
Price & Trading
| Last Close | $73.31 |
| 50-Day MA | $79.42 |
| 200-Day MA | $59.40 |
| Avg Volume | 173K |
| Beta | -0.8 |
|
52-Week Range
$23.18
| |
About BRIGHT MINDS BIOSCIENCES INC. (DRUG)
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is BRIGHT MINDS BIOSCIENCES INC. (DRUG) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), BRIGHT MINDS BIOSCIENCES INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is BRIGHT MINDS BIOSCIENCES INC.'s debt ratio?
BRIGHT MINDS BIOSCIENCES INC.'s debt ratio is 0.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.1%.
What are BRIGHT MINDS BIOSCIENCES INC.'s key financial metrics?
BRIGHT MINDS BIOSCIENCES INC. has a market capitalization of $686M. Return on equity stands at -27.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.